Below is a list of upcoming stem cell and regenerative medicine conferences and meetings for 2016. You can see the meeting list for 2020 here. The new year has a lot to offer in our field. If you do not see your meeting, please let me know and I will include it. This list is …
Over the past half dozen or so years I’ve seen far more physicians describing themselves as a “stem cell doctor” or a “stem cell specialist.” Is there such a thing? Are they just saying that to attract and reassure potential customers getting unproven stem cell shots? What does Google think is a stem cell doctor? …
After the COVID-19 pandemic started clinical trials quickly sprouted up to test various kinds of cell therapy for COVID-19 including stem cells. The most common rationale for this approach is to suppress damaging overactive immune responses. Trials of cell therapy for COVID-19 including stem cells I’ve written quite a lot about these cellular medicine and …
Our new paper assessing trials of cell therapy for COVID-19 Read More »
Sometimes the recommended weekly stem cell reads are just a bunch of papers I find intriguing, but more often they include at least one or more things that are not necessarily “recommended”. Instead these are items that stimulate discussion and debate. Today’s post includes one such complicated area on cord MSCs related to COVID-19 plus …
Weekly stem cell reads: Pew, cord cells for COVID, more Read More »
In the stem cell world some corporate names end up being very similar with the latest example being several companies with the name “BioLife.” Get a BioLife…name I guess BioLife is a catchy term. You’ve got life and biology in there in one name. Let’s deconstruct what’s going on out there with this corporate name. …
Perspectives on BioLife: one name, distinct companies Read More »
What might be most surprising about this week’s recommended stem cell research reads is there’s nothing about COVID-19 in here. There are, however, some really great papers. And we can expect more developments on the cellular medicine for COVID-19 front coming soon. Before I jump into the reads, if you haven’t already check out our …
Weekly stem cell research reads: BAF, Polycomb, Fertility, More Read More »
Here are my recommended weekly reads for The Niche readership for early February 2021 including COVID-19 and stem cell lawsuit updates, papers, and more. How many papers do you end up reading each week or month these days? More or less than before the pandemic? COVID-19 updates New diabetes cases linked to covid-19, WaPo ICYMI …
The Niche reads: COVID, new INDs, clinic suits, papers Read More »
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new study such as one of the authors describing the …
Small umbilical cord stem cell COVID-19 trial: sign of efficacy? Read More »
Even in COVID times the FDA continues its stepped-up efforts against stem cell clinics and patients are suing clinics more too, which I cover in today’s post along with recommended stem cell research pubs. One of the papers at the top of my to-read list is on 3D chromatin in stem cells. FDA Warning Letter …
The COVID-19 pandemic is tearing through the country right as we are starting into the holiday season, but the wheels of science including cell biology keep going and we keep reading all the great work. What news or papers caught your eye? Here are some of the things I have on my list of reading. …
Weekend cell biology reads: Mesoblast COVID-19 deal, pubs Read More »